Biodesix Statistics

Total Valuation

Biodesix has a market cap or net worth of $228.38 million. The enterprise value is $259.48 million.

Market Cap	228.38M
Enterprise Value	259.48M

Important Dates

The last earnings date was Friday, November 1, 2024, before market open.

Earnings Date	Nov 1, 2024
Ex-Dividend Date	n/a

Share Statistics

Biodesix has 145.47 million shares outstanding. The number of shares has increased by 57.83% in one year.

Current Share Class	145.47M
Shares Outstanding	145.47M
Shares Change (YoY)	+57.83%
Shares Change (QoQ)	+15.04%
Owned by Insiders (%)	47.60%
Owned by Institutions (%)	35.50%
Float	66.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.77
Forward PS	2.61
PB Ratio	8.20
P/TBV Ratio	35.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 2.24.

Current Ratio	3.40
Quick Ratio	3.04
Debt / Equity	2.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.91

Financial Efficiency

Return on equity (ROE) is -331.82% and return on invested capital (ROIC) is -30.74%.

Return on Equity (ROE)	-331.82%
Return on Assets (ROA)	-22.79%
Return on Capital (ROIC)	-30.74%
Revenue Per Employee	$302,129
Profits Per Employee	-$201,931
Employee Count	217
Asset Turnover	0.69
Inventory Turnover	11.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.88% in the last 52 weeks. The beta is 1.14, so Biodesix's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-1.88%
50-Day Moving Average	1.43
200-Day Moving Average	1.53
Relative Strength Index (RSI)	65.15
Average Volume (20 Days)	332,475

Short Selling Information

The latest short interest is 624,230, so 0.43% of the outstanding shares have been sold short.

Short Interest	624,230
Short Previous Month	388,861
Short % of Shares Out	0.43%
Short % of Float	0.95%
Short Ratio (days to cover)	0.83

Income Statement

In the last 12 months, Biodesix had revenue of $65.56 million and -$43.82 million in losses. Loss per share was -$0.38.

Revenue	65.56M
Gross Profit	50.96M
Operating Income	-34.56M
Pretax Income	-44.51M
Net Income	-43.82M
EBITDA	-29.26M
EBIT	-34.56M
Loss Per Share	-$0.38

Full Income Statement

Balance Sheet

The company has $31.41 million in cash and $62.50 million in debt, giving a net cash position of -$31.09 million or -$0.21 per share.

Cash & Cash Equivalents	31.41M
Total Debt	62.50M
Net Cash	-31.09M
Net Cash Per Share	-$0.21
Equity (Book Value)	27.86M
Book Value Per Share	0.19
Working Capital	31.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.84 million and capital expenditures -$5.38 million, giving a free cash flow of -$62.21 million.

Operating Cash Flow	-56.84M
Capital Expenditures	-5.38M
Free Cash Flow	-62.21M
FCF Per Share	-$0.43

Full Cash Flow Statement

Margins

Gross margin is 77.72%, with operating and profit margins of -52.71% and -66.84%.

Gross Margin	77.72%
Operating Margin	-52.71%
Pretax Margin	-66.84%
Profit Margin	-66.84%
EBITDA Margin	-44.63%
EBIT Margin	-52.71%
FCF Margin	n/a

Dividends & Yields

Biodesix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.83%
Shareholder Yield	-57.83%
Earnings Yield	-19.19%
FCF Yield	-27.24%

Analyst Forecast

The average price target for Biodesix is $3.08, which is 96.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.08
Price Target Difference	96.18%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biodesix has an Altman Z-Score of -4.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.85
Piotroski F-Score	3